Trials / Completed
CompletedNCT04369365
A Single-blinded, Randomized, Placebo Controlled Phase II Trial of Prophylactic Treatment With Oral Azithromycin Versus Placebo in Cancer Patients Undergoing Antineoplastic Treatment During the Corona Virus Disease 19 (COVID-19) Pandemic
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 74 (actual)
- Sponsor
- Prof. Dr. Matthias Preusser · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Prophylactic treatment in cancer patients undergoing antineoplastic therapy during the COVID-19 pandemic.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Azithromycin 500 milligram (mg) oral Tablet | weekly oral use |
| DRUG | Placebo | weekly oral use |
Timeline
- Start date
- 2020-04-27
- Primary completion
- 2021-06-15
- Completion
- 2021-06-15
- First posted
- 2020-04-30
- Last updated
- 2022-04-07
Locations
1 site across 1 country: Austria
Source: ClinicalTrials.gov record NCT04369365. Inclusion in this directory is not an endorsement.